Douglas Fambrough

Insider Reports History

Entity
Individual
Location
C/O Dicerna Pharmaceuticals, Inc., 75 Hayden Avenue, Lexington, MA
Signature
/s/ Brian J. Shea, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas Fambrough:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncorus, Inc. Director Stock Option (right to buy) 25K Jun 22, 2022 Direct
Dicerna Pharmaceuticals Inc Chief Executive Officer, Director Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Chief Executive Officer, Director Restricted Stock Units 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Chief Executive Officer, Director Employee Stock Option (Right to Buy) 0 Dec 28, 2021 By Trust
Dicerna Pharmaceuticals Inc Chief Executive Officer, Director Employee Stock Option (Right to Buy) 0 Dec 28, 2021 Direct

Insider Reports Filed by Douglas Fambrough

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCR Oncorus, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
ONCR Oncorus, Inc. Jun 22, 2022 0 $0 3 Jun 24, 2022 Director
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 15 -$8.85M 4 Dec 29, 2021 Chief Executive Officer, Director
DRNA Dicerna Pharmaceuticals Inc Dec 15, 2021 3 -$203K 4 Dec 17, 2021 Chief Executive Officer, Director
DRNA Dicerna Pharmaceuticals Inc Dec 10, 2021 4 $600K 4 Dec 13, 2021 Chief Executive Officer, Director
DRNA Dicerna Pharmaceuticals Inc Aug 10, 2021 1 $110K 4 Aug 10, 2021 President and CEO, Director